Prostate cancer morbidity and mortality are rising in Asia, with current diagnoses mainly relying on PSA, digital rectal exam (DRE) and mpMRI, as as reported above, posing a new challenge to PCa diagnosis. This evidence concerns the gene KLK3 and prostate cancer.